0001209191-21-002410.txt : 20210106 0001209191-21-002410.hdr.sgml : 20210106 20210106210507 ACCESSION NUMBER: 0001209191-21-002410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoelscher Paul W. CENTRAL INDEX KEY: 0001611468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 21512714 MAIL ADDRESS: STREET 1: 520 LAKE COOK ROAD, SUITE 520 STREET 2: C/O HORIZON PHARMA, INC. CITY: DEERFIELD STATE: IL ZIP: 60062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001611468 Hoelscher Paul W. C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, CFO Ordinary Shares 2021-01-05 4 M 0 98192 A 99241 D Ordinary Shares 2021-01-05 4 A 0 205638 0.00 A 304879 D Ordinary Shares 2021-01-05 4 F 0 134698 73.28 D 170181 D Ordinary Shares 102925 I By Trust Restricted Stock Units (RSU) 2021-01-04 4 A 0 34928 0.00 A Ordinary Shares 34928 34928 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 17983 0.00 D Ordinary Shares 17983 17983 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 65696 0.00 D Ordinary Shares 65696 0 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 14513 0.00 D Ordinary Shares 14513 29028 D Each RSU represents a contingent right to receive one ordinary share of the Issuer. On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above. The RSU's vest 1/3rd annually on each anniversary of January 5, 2020. The RSU's vest 1/3rd annually on each anniversary of January 5, 2019. The RSU's vest 1/3rd annually on each anniversary of January 5, 2018. /s/ Miles W. McHugh, Attorney-in-Fact 2021-01-06